NCT03246971View on ClinicalTrials.gov

Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 24, 2017

Primary Completion Date

July 12, 2018

Study Completion Date

July 17, 2018

Conditions
Acute PainBunionAbdominoplasty
Interventions
DRUG

Wafermine™ 50 mg

Administered as needed for 12 hours

DRUG

Wafermine™ 75 mg

Administered as needed for 12 hours

DRUG

Placebos

Administered as needed for 12 hours

DRUG

Wafermine™ 25 mg

Administered as needed for 12 hours

Trial Locations (1)

91105

Lotus Clinical Research, Pasadena

All Listed Sponsors
lead

iX Biopharma Ltd.

OTHER

NCT03246971 - Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain | Biotech Hunter | Biotech Hunter